Table 1.
Baseline characteristics of participants enrolled and completing follow-up (n = 421)
| Variables | Maferinyah (n = 211) | Labé (n = 210) | ||
|---|---|---|---|---|
| ASAQ | AL | ASAQ | AL | |
| Participant characteristics at baseline | ||||
| Median age, in month (interquartile range) | 36 (24–48) | 36 (24–59) | 45 (24–59) | 36 (24–48) |
| Median weight, kg (interquartile range) | 14 (10–16) | 13 (11–16) | 13 (10–16) | 13 (10–15) |
| Percent female, n (%) | 55 (51.4) | 39 (37.5) | 40 (38.1) | 43 (41.0) |
| Median day 0 parasitemia, parasites/µl * 103 (interquartile range) | 19.4 (101–519) | 27.4 (10.2–55.0) | 30.2 (13.0–63.9) | 30,450 (13.1–49.6) |
| Median day 0 haemoglobin, g/dl (interquartile range) | 9.7 (8–10) | 9.8 (8–10) | 10.7 (9–11) | 10.6 (8.5–11) |
AL artemether–lumefantrine, ASAQ artesunate–amodiaquine